We advise start-up and accelerator CEOs, partner with investors by conducting thorough due diligence to facilitate the decision-making process.


Instrumental in connecting Canadian start-ups with an influential network of key opinion leaders and business executives. Invaluable resource to founders in CELS program demonstrating a real commitment to the success of these companies and the economic advancement of Canada. Programs like CELS would be not possible without such leaders sharing your experience and network - thank you!


Given our core areas of expertise, we advise biotech start-ups and accelerators on how to enhance their value proposition for payers and providers.

We facilitate robust introductions and strategize initiatives that increase their chances of securing funding and accessing global markets.


We partner with investors to conduct thorough due diligence on their target medical technologies, assess the viability of the ventures through evaluation of business plans, and identify potential risks while offering strategic recommendations.

Our vantage point is review of safety, medical merit, feasibility, market potential, and competitive landscape of the medical products and provide invaluable insights to utilize in decision making.

Noteworthy contributions to Technology and Sales aspects of due diligence process. Critical insights about the target market, safety standards, and certifications, demonstrating persistence and cordiality. Great rapport with the company management and the entire due diligence team, displaying resilience and resourcefulness in finding solutions.

Evidence Based Commercial Success

We Are Here to Make an Impact for You